Honokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinoma

References

• Allen TM, Cullis PR. (2004). Drug delivery systems: entering the mainstream. Science 303:1818–22
   PubMed Web of Science ®Google Scholar
• Arora S, Bhardwaj A, Srivastava SK, et al. (2011). Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS One 6:e21573
   PubMed Web of Science ®Google Scholar
• Arora S, Singh S, Piazza GA, et al. (2012). Honokiol: a novel natural agent for cancer prevention and therapy. Curr Mol Med 12:1244–52
   PubMed Web of Science ®Google Scholar
• Chen HC, Hsu HT, Weng JW, et al. (2016). Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells. J Chin Med Assoc 79:415–21
   PubMed Web of Science ®Google Scholar
• Chen L, Hu CS, Chen XZ, et al. (2012). Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol 13:163–71
   PubMed Web of Science ®Google Scholar
• Chen LC, Lee WS. (2013). P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo. J Agric Food Chem 61:2811–19
   PubMed Web of Science ®Google Scholar
• Cheng YC, Hueng DY, Huang HY, et al. (2016). Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas. Oncotarget 7:29116–30
   PubMed Web of Science ®Google Scholar
• Cho JH, Jeon YJ, Park SM, et al. (2015). Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft. Biomaterials 53:274–84
   PubMed Web of Science ®Google Scholar
• Deng J, Qian Y, Geng L, et al. (2008). Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2). Liver Int 28:1458–64
   PubMed Web of Science ®Google Scholar
• Fang F, Gong C, Qian Z, et al. (2009). Honokiol nanoparticles in thermosensitive hydrogel: therapeutic effects on malignant pleural effusion. ACS Nano 3:4080–8
   PubMed Web of Science ®Google Scholar
• Fried LE, Arbiser JL. (2009). Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 11:1139–48
   PubMed Web of Science ®Google Scholar
• Fu SZ, Wang XH, Guo G, et al. (2011). Preparation and properties of nano-hydroxyapatite/PCL-PEG-PCL composite membranes for tissue engineering applications. J Biomed Mater Res B Appl Biomater 97:74–83
   PubMed Web of Science ®Google Scholar
• Gou M, Gong C, Zhang J, et al. (2010). Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel. J Biomed Mater Res A 93:219–26
   PubMed Web of Science ®Google Scholar
• Gou M, Li X, Dai M, et al. (2008). A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel. Int J Pharm 359:228–33
   PubMed Web of Science ®Google Scholar
• Gou M, Zheng L, Peng X, et al. (2009). Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Int J Pharm 375:170–6
   PubMed Web of Science ®Google Scholar
• Hahm ER, Singh KB, Singh SV. (2016). c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells. Cell Cycle 15:2309–20
   PubMed Web of Science ®Google Scholar
• Hahm ER, Singh SV. (2007). Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 6:2686–95
   PubMed Web of Science ®Google Scholar
• Huang Y, Yang T, Zhang W, et al. (2014). A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo. Int J Nanomedicine 9:4581–95
   PubMed Web of Science ®Google Scholar
• Hwang-Bo J, Yoo KH, Park JH, et al. (2012). Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis. Int J Cancer 131:298–309
   PubMed Web of Science ®Google Scholar
• Jeong JJ, Lee JH, Chang KC, Kim HJ. (2012). Honokiol exerts an anticancer effect in T98G human glioblastoma cells through the induction of apoptosis and the regulation of adhesion molecules. Int J Oncol 41:1358–64
   PubMed Web of Science ®Google Scholar
• Li Z, Liu Y, Zhao X, et al. (2008). Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol 140:95–102
   PubMed Web of Science ®Google Scholar
• Liu H, Zang C, Emde A, et al. (2008). Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol 591:43–51
   PubMed Web of Science ®Google Scholar
• Luo H, Zhong Q, Chen LJ, et al. (2008). Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer. J Cancer Res Clin Oncol 134:937–45
   PubMed Web of Science ®Google Scholar
• Park EJ, Min HY, Chung HJ, et al. (2009). Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett 277:133–40
   PubMed Web of Science ®Google Scholar
• Shi F, Yang G, Ren J, et al. (2013a). Formulation design, preparation, and in vitro and in vivo characterizations of beta-Elemene-loaded nanostructured lipid carriers. Int J Nanomedicine 8:2533–41
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang H, Wang L, et al. (2013b). PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials 34:251–61
   PubMed Web of Science ®Google Scholar
• Shi S, Shi K, Tan L, et al. (2014). The use of cationic MPEG-PCL-g-PEI micelles for co-delivery of Msurvivin T34A gene and doxorubicin. Biomaterials 35:4536–47
   PubMed Web of Science ®Google Scholar
• Singh T, Gupta NA, Xu S, et al. (2015). Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor. Oncotarget 6:21268–82
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108
   PubMed Web of Science ®Google Scholar
• Wang T, Chen F, Chen Z, et al. (2004). Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 10:2205–8
   PubMed Web of Science ®Google Scholar
• Wang X, Beitler JJ, Wang H, et al. (2014). Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PLoS One 9:e86369
   PubMed Web of Science ®Google Scholar
• Xie M, zhang H, Xu Y, et al. (2013). Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine. Int J Nanomedicine 8:2443–51
   PubMed Web of Science ®Google Scholar
• Xu Z, Liu S, Liu H, et al. (2015). Unimolecular micelles of amphiphilic cyclodextrin-core star-like block copolymers for anticancer drug delivery. Chem Commun (Camb) 51:15768–71
   PubMed Web of Science ®Google Scholar
• You H, Fu S, Qin X, et al. (2016). A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma. Colloids Surf B Biointerfaces 140:150–60
   PubMed Web of Science ®Google Scholar
• Younes-Mhenni S, Janier MF, Cinotti L, et al. (2004). FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 127:2331–8
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhao W, Ye C, et al. (2015a). Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis. Oncotarget 6:37335–48
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen T, Yuan P, et al. (2015b). Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells. Carbohydr Polym 133:31–8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ren X, Shi M, et al. (2014). Downregulation of STAT3 and activation of MAPK are involved in the induction of apoptosis by HNK in glioblastoma cell line U87. Oncol Rep 32:2038–46
   PubMed Web of Science ®Google Scholar
• Zheng X, Kan B, Gou M, et al. (2010). Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro. Int J Pharm 386:262–7
   PubMed Web of Science ®Google Scholar
• Zhou YY, Du YZ, Wang L, et al. (2010). Preparation and pharmacodynamics of stearic acid and poly (lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin. Int J Pharm 393:143–51
   PubMed Web of Science ®Google Scholar